Indications and Usage Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg and Ozempic (semaglutide) tablets 4 mg or 9 mg are indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes Ozempic injection is indicated: to reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes and established CV disease to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease Ozempic tablets are indicated: to reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes who are at high risk for these events
Inne to np
J Clin Endocrinol Metab (2003) 88:240411
10.1016/j.jid.2021.08.326 22 KhatifH.BazziH
In these settings, glucose dysregulation, visceral adiposity, fatty liver, vascular inflammation, and chronic low-grade inflammation often reinforce one another, creating a cascade of metabolic stress that accelerates functional decline
Topline results released last month from the Phase III ATTAIN-MAINTAIN trial (NCT06584916) found that over 52 weeks, orforglipron achieved the primary endpoint in producing superior percent maintenance of weight loss vs
